Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

SKB reports fibrinogen antagonists

Aug. 16, 1996

Corvas discloses thrombin inhibitors

Aug. 16, 1996

Kanebo reports Na+/H+ exchange inhibitors

Aug. 16, 1996

Antihypertensive quinazoline derivatives described by Nippon Chemiphar

Aug. 16, 1996

American Cyanamid claims vasopressin antagonists

Aug. 16, 1996

SKB discloses drugs for IL-8-mediated disorders

Aug. 16, 1996

PDE IV inhibitors claimed by Euroceltique

Aug. 16, 1996

Taisho describes NGF production promotors

Aug. 16, 1996

GABA-A receptor ligands disclosed by Synthelabo

Aug. 16, 1996

Meiji Seika claims bicyclic thiazoles for CNS disorders

Aug. 16, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
IMV-101 shows promise for B-cell malignancies
BioWorld Science
IMV-101 is a new CAR T-cell therapy targeting CD19 developed by Suzhou Immunofoco Biotechnology Co. Ltd. for the potential treatment of B-cell malignancies and...